Miracle Mile Advisors, LLC Biogen Inc. Transaction History

Miracle Mile Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 13, 2023	BUY	$275.25 - $318.06 $6,881 - $7,951	25 Added 3.36%	769 $219,000
Q4 2022 Jan 20, 2023	BUY	$252.44 - $306.72 $187,815 - $228,199	744 New	744 $0
Q4 2021 Jan 18, 2022	SELL	$223.92 - $287.77 $166,596 - $214,100	-744 Closed	0 $0
Q3 2021 Nov 01, 2021	SELL	$282.99 - $369.05 $11,885 - $15,500	-42 Reduced 5.34%	744 $211,000
Q2 2021 Jul 28, 2021	SELL	$259.0 - $414.71 $57,757 - $92,480	-223 Reduced 22.1%	786 $272,000
Q1 2021 Apr 29, 2021	SELL	$242.95 - $284.63 $1,700 - $1,992	-7 Reduced 0.69%	1,009 $282,000
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $796,163 - $919,269	-3,007 Reduced 74.75%	1,016 $288,000
Q2 2020 Aug 06, 2020	BUY	$258.66 - $342.55 $1.04 Million - $1.38 Million	4,023 New	4,023 $1.08 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Miracle Mile Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Miracle Mile Advisors, LLC with notifications on news.